Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402

Follistatin is an angiogenic factor elevated in the circulation after allogeneic hematopoietic cell transplantation (HCT). Elevations in follistatin plasma concentrations are associated with the onset of and poor survival after acute GvHD (aGvHD). Using data from the Blood and Marrow Transplant Clin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2018-01, Vol.53 (1), p.64-68
Hauptverfasser:	Turcotte, L M, DeFor, T E, Newell, L F, Cutler, C S, Verneris, M R, Wu, J, Howard, A, MacMillan, M L, Antin, J H, Vercellotti, G M, Slungaard, Ane, Blazar, B R, Weisdorf, D J, Panoskaltsis-Mortari, A, Holtan, S G
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/575 692/700/1750/1976 Acute Disease Adolescent Adult Angiogenesis Biomarkers Blood Bone marrow transplantation Cell Biology Child Clinical trials Confidence intervals Development and progression Female Follistatin Follistatin - adverse effects Genetic aspects Graft vs Host Disease - etiology Graft vs Host Disease - pathology Graft vs. host disease Graft-versus-host reaction Health aspects Hematology Hematopoietic stem cell transplantation Humans Internal Medicine Male Medical research Medicine Medicine & Public Health Middle Aged Mortality original-article Physiological aspects Public Health Risk Stem cell transplantation Stem Cells Survival Tissue Donors Transplantation Transplants & implants Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!